Iridex (IRIX) Return on Capital Employed Growth (1y) (2012 - 2026)
Iridex (IRIX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.00 |
| 10 | Iridex | 15.41 Mn | 10.81 Mn | 4.74 Mn | 1,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,422.00 |
| Jan 3, 2026 | 4,691.00 |
| Sep 27, 2025 | 5,588.00 |
| Jun 28, 2025 | 4,643.00 |
| Mar 29, 2025 | 2,905.00 |
| Dec 28, 2024 | -1,738.00 |
| Sep 28, 2024 | -4,071.00 |
| Jun 29, 2024 | -3,353.00 |
| Mar 30, 2024 | -3,348.00 |
| Dec 30, 2023 | -2,188.00 |
| Sep 30, 2023 | -926.00 |
| Jul 1, 2023 | -847.00 |
| Apr 1, 2023 | -765.00 |
| Dec 31, 2022 | -692.00 |
| Oct 1, 2022 | -472.00 |
| Jul 2, 2022 | -330.00 |
| Apr 2, 2022 | 1,215.00 |
| Apr 3, 2021 | -89.00 |
| Mar 28, 2020 | 864.00 |
| Dec 28, 2019 | 504.00 |